Nasdaq - Delayed Quote USD

Lord Abbett Health Care C (LHCCX)

17.06
+0.07
+(0.41%)
At close: 8:01:27 PM EDT

Top 10 Holdings (40.46% of Total Assets)

SymbolCompany% Assets
Eli Lilly and Company 8.74%
Boston Scientific Corporation 4.92%
Intuitive Surgical, Inc. 4.78%
Gilead Sciences, Inc. 3.94%
Stryker Corporation 3.74%
argenx SE 3.56%
Natera, Inc. 3.06%
Tarsus Pharmaceuticals, Inc. 2.94%
Cencora, Inc. 2.61%
UCB SA 2.14%

Sector Weightings

SectorLHCCX
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Cash 0.00%
Stocks 100.00%
Bonds 0.00%
Others 0.00%
Preferred 0.00%
Convertible 0.00%

Bond Ratings

Equity Holdings

Average LHCCX Category Average
Price/Earnings 0.02 24.55
Price/Book 0.16 5.28
Price/Sales 0.3 2.06
Price/Cashflow 0.04 17.54
Median Market Cap 27,458.44 34,862.81
3 Year Earnings Growth 10.33 32.48

Bond Holdings

Performance & Risk

YTD Return -7.66%
5y Average Return 4.24%
Rank in Category (ytd) 78
% Rank in Category (ytd) --
Beta (5Y Monthly) 0.76
Morningstar Risk Rating

Fund Overview

Category Health
Fund Family Lord Abbett
Net Assets 7.51M
YTD Return -4.29%
Yield 0.00%
Morningstar Rating
Inception Date Jul 31, 2019

Fund Summary

Under normal conditions, the fund will invest at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in equity and equity-related securities of health care-related companies. The Advisor considers health care-related companies to be those companies that operate in, or are related to, the major subsectors of the health care sector, including pharmaceuticals, biotechnology, health care technology, life sciences tools and services, health care equipment and supplies, and health care providers and services.

Related Tickers